MétaCan
Menu
Back to cohort

Abstract P038: Identification and functional evaluation of monoclonal antibodies specifically targeting human Carbonic Anhydrase IX

2022· article· en· W4205606019 on OpenAlexaff
Anne E.G. Lenferink, Jason Baardsnes, Traian Sulea, Cunle Wu, Maurizio Acchione, María Jaramillo, Paul C. McDonald, François Bénard, Shoukat Dedhar

Bibliographic record

VenueCancer Immunology Research · 2022
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicEnzyme function and inhibition
Canadian institutionsSpinal Cord Injury BCNational Research Council Canada
Fundersnot available
KeywordsTumor hypoxiaMonoclonal antibodyCancer researchHypoxia (environmental)Carbonic anhydraseBiologyAntibodyChemistryBiochemistryRadiation therapyEnzymeMedicineImmunologyInternal medicine

Abstract

fetched live from OpenAlex

Abstract Poor vascularization of solid tumors leads to inadequate nutrient and oxygen supplies which forces tumor cells to reprogram their metabolism. Consequently, the tumor cell's environment becomes acidic and hypoxic. This triggers signaling cascades involving e.g. heterodimeric hypoxia-inducible factor (HIF). Activation of this hypoxia-induced transcriptional program is crucial for the tumor cell to survive its hostile microenvironment and its ability to metastasize. One of the genes HIF upregulated is carbonic anhydrase (CA)-IX (CAIX, gene G250/MN-encoded transmembrane protein). CA-IX catalyzes carbon dioxide (CO2) thereby generating a proton (H+) and bicarbonate (HCO3−), the latter of which is transported back into the cell and utilized to help safeguard intracellular pH (pHi) stability. Except for the stomach and the gallbladder, CA-IX expression is negligible in normal tissues. In contrast, a broad range of tumors express high levels of CA-IX, where the protein can serve as a biomarker for the early stages of tumor development but also as tumor marker of hypoxia associated with resistance to chemotherapy and radiotherapy. Preclinical and clinical studies have shown that CA-IX is a promising therapeutic target for detection and therapy for several cancer types. To date only a limited number of ant-CAIX monoclonal antibodies (mAbs) have been available for clinical testing as therapeutic and imaging agents. In the current study, we generated and functionally categorized a panel of 51 mouse mAbs that specifically bind to human CA-IX. Characterization of the mAbs revealed that of the mAbs with the best biophysical characteristics, three (3) mAbs are suitable as an antibody-drug conjugate (ADC), two (2) mAbs inhibit the CA-IX enzyme activity, and one (1) mAb that is suitable for CA-IX imaging purposes. These preliminary data presented here could thus form the basis for the development of novel CA-IX targeted immunotherapies and diagnostic tools for the treatment of cancer. Citation Format: Anne E. G. Lenferink, Jason Baardsnes, Traian Sulea, Cunle Wu, Maurizio Acchione, Maria L. Jaramillo, Paul C. McDonald, Francois Benard, Shoukat Dedhar. Identification and functional evaluation of monoclonal antibodies specifically targeting human Carbonic Anhydrase IX [abstract]. In: Abstracts: AACR Virtual Special Conference: Tumor Immunology and Immunotherapy; 2021 Oct 5-6. Philadelphia (PA): AACR; Cancer Immunol Res 2022;10(1 Suppl):Abstract nr P038.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.004

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.096
GPT teacher head0.386
Teacher spread0.290 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2022
Admission routes1
Has abstractyes

Explore more

Same venueCancer Immunology ResearchSame topicEnzyme function and inhibitionFrench-language works237,207